INDUCTION OF PROTECTIVE IMMUNITY AGAINST TRANSMISSIBLE GASTROENTERITIS VIRUS AFTER EXPOSURE OF NEONATAL PIGS TO PORCINE RESPIRATORY CORONAVIRUS

Citation
Rd. Wesley et Rd. Woods, INDUCTION OF PROTECTIVE IMMUNITY AGAINST TRANSMISSIBLE GASTROENTERITIS VIRUS AFTER EXPOSURE OF NEONATAL PIGS TO PORCINE RESPIRATORY CORONAVIRUS, American journal of veterinary research, 57(2), 1996, pp. 157-162
Citations number
20
Categorie Soggetti
Veterinary Sciences
ISSN journal
00029645
Volume
57
Issue
2
Year of publication
1996
Pages
157 - 162
Database
ISI
SICI code
0002-9645(1996)57:2<157:IOPIAT>2.0.ZU;2-B
Abstract
Objective-To test the ability of porcine respiratory coronavirus (PRCV ) to induce protective immunity to antigenically related transmissible gastroenteritis virus (TGEV) in neonatal pigs. Design-Neonatal pigs w ere exposed to PRCV when they were 2, 4, or 6 days old and challenge-e xposed to virulent TGEV at 10 days of age. Animals-34 hysterectomy-der ived, colostrum-deprived pigs. Procedure-After challenge exposure, cli nical signs were observed, body weight, antibody response, and virus s hedding were measured, and mortality was determined. Results-After exp osure to PRCV, principals had a slightly slower rate of weight gain th an did controls; with 1 exception (a PRCV-exposed pig that was dyspnei c for 1 day), principals and controls remained clinically normal until shortly after challenge exposure, when ail pigs became listless and a norectic and developed watery diarrhea. However, by day 3, most of the pigs that had been exposed to PRCV when they were either 2 or 4 days old began to recover and most (15/18) survived. Conversely, the clinic al condition of most of the other pigs worsened and most (14/16) died. Pigs exposed to PRCV when they were 2 or 4 days old also differed fro m all other pigs in that they had serum virus-neutralizing antibodies for PRCV and TGEV at the time of challenge exposure. Conclusions-The P RCV can induce protective immunity to TGEV in neonatal pigs and such i mmunity develops at or about 6 days after exposure to PRCV. Moreover, protective immunity may be coincident with the appearance of virus-neu tralizing antibody. Clinical Relevance-Exposure to PRCV should enhance a TGE herd vaccination program.